Apolipoprotein B

Home - Reagents - Apolipoprotein B
reagents-logo

Key Benefits

Wide measuring range

With a measuring range of 9.37–233 mg/dl, it will comfortably detect levels outside of the healthy range of 63-114mg/dl

Excellent stability

Stable to expiry when stored at 2-8°C

Liquid ready-to-use reagents

The Randox Apolipoprotein B reagent comes in a liquid format which is more convenient, and can also help reduce the risk of errors occurring

Other features

  • Immunoturbidimetric
  • Liquid ready-to-use reagents
  • Stable to expiry when stored at 2-8°C
  • Measuring range 9.37 – 233 mg/dl
Cat NoSizeAnalyserEasy Read
Easy Fit
 
(C) Indicates calibrator included in kit
LP2117R1 4 x 50ml (C)
R2 4 x 9ml
General Use--
LP2990R1 4 x 60ml (C)
R2 4 x 15ml
Hitachi 917/Mod P
Abbott Architect
Konelab 20i/30i/60i
Beckman Coulter AU Series






LP3839R1 4 x 20ml
R2 4 x 6ml
RX Daytona/Imola
Hitachi 717/911/912/704/902


LP8008R1 2 x 10ml
R2 2 x 4ml
RX Suzuka
Abbott Architect
Hitachi 917/Mod P
Konelab 20i/30i/60i
Beckman Coulter AU Series








Instrument Specific Applications (ISA’s) are available for a wide range of biochemistry analysers.  Contact us to enquire about your specific analyser.

What is Apolipoprotein B assay used for?

The B Apolipoproteins are the main form of protein found in Low Density Lipoproteins (LDL). Two forms of APO B are found in humans. APO B is the main cholesterol carrying protein in the blood and is the ligand concerned with the uptake of cholesterol into cells by the LDL-receptor pathway. APO B shows atherogenic signs and is thus useful for the evaluation of coronary risk.

The test is undertaken:

  • When the patient has a personal or family history of heart disease and/or high concentrations of lipids in the blood
  • To determine the patient’s risk of developing CVD
  • To help monitor treatment for hyperlipidaemia
  • To help diagnose APO B deficiency
  • Chen, H-L., et al. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects-a randomized double-blind trial. J. Am. Coll. Nutr. 2003, 22(1): 36-42.
  • Goswami, B., et al. Apo-B/apo AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction. Acta. Cardiol. 2008, 63(6): 749-755.
  • Ganguli, D., et al. Association between inflammatory markers and cardiovascular risk factors in women from Kolkata, W.B, India. Arq. Bras. Cardiol. 2011, 96(1): Epub.
  • Li, S.C., et al. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2011, 60(4): 474-479.
  • Yahaya, N. et al. Type 2 diabetes with good glycemic control have improved insulin response and lower non-esterified fatty acid level after a meal challenge. Journal of Diabetes Mellitus 2012, 2(1): 1-7.
Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
  • This field is for validation purposes and should be left unchanged.
×
Kit Insert Request - Reagents
×
Kit Insert Request - Reagents
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Reagents
×
Por favor, introduzca sus datos para ver nuestro último seminario
×